Cargando…

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome

The self-immunopeptidome is the repertoire of all self-peptides that can be presented by the combination of MHC variants carried by an individual, defined by their HLA genotype. Each MHC variant presents a distinct set of self-peptides, and the number of peptides in a set is variable. Subjects carry...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Scott D., Holt, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350689/ https://www.ncbi.nlm.nih.gov/pubmed/30723589 http://dx.doi.org/10.1080/2162402X.2018.1556080

Ejemplares similares

MHC Class I Immunopeptidome: Past, Present, and Future
por: Yewdell, Jonathan W.
Publicado: (2022)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways
por: Zaitouna, Anita J., et al.
Publicado: (2020)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022)

A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018)

Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation
por: Pyke, Rachel Marty, et al.
Publicado: (2021)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
por: Leddy, Owen, et al.
Publicado: (2023)

The yin/yang balance of the MHC-self-immunopeptidome
por: Santambrogio, Laura, et al.
Publicado: (2022)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
por: Santambrogio, Laura
Publicado: (2022)

Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines
por: Mohan, Sonali V., et al.
Publicado: (2021)

Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes
por: Olsson, Niclas, et al.
Publicado: (2022)

The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
por: Bedran, Georges, et al.
Publicado: (2023)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
por: Kuznetsov, Alexandr, et al.
Publicado: (2020)

Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation
por: Iizuka, Akira, et al.
Publicado: (2023)

An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
por: Olsson, Niclas, et al.
Publicado: (2021)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome
por: Sturm, Theo, et al.
Publicado: (2020)

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
por: Caron, Etienne, et al.
Publicado: (2011)

Solving an MHC allele–specific bias in the reported immunopeptidome
por: Klatt, Martin G., et al.
Publicado: (2020)

Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I
por: Mangalaparthi, Kiran K., et al.
Publicado: (2021)

Investigating the human and nonobese diabetic mouse MHC class II immunopeptidome using protein language modeling
por: Hartout, Philip, et al.
Publicado: (2023)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)

Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
por: Minegishi, Yuriko, et al.
Publicado: (2022)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
por: Kaabinejadian, Saghar, et al.
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition
por: Sandalova, Tatyana, et al.
Publicado: (2022)

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
por: Boehm, Kevin Michael, et al.
Publicado: (2019)

Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
por: Stopfer, Lauren E., et al.
Publicado: (2020)

Gorilla MHC class I gene and sequence variation in a comparative context
por: Hans, Jörg B., et al.
Publicado: (2017)

MHC-II neoantigens shape tumor immunity and response to immunotherapy
por: Alspach, Elise, et al.
Publicado: (2019)

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
por: Ren, Yingxue, et al.
Publicado: (2020)

MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)

Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
por: Qi, Yue A., et al.
Publicado: (2021)

Adaptations of Natural Killer Cells to Self-MHC Class I
por: Bessoles, Stéphanie, et al.
Publicado: (2014)

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope
por: Swartz, Adam M., et al.
Publicado: (2021)

Predicting MHC class I epitopes in large datasets
por: Roomp, Kirsten, et al.
Publicado: (2010)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression
por: Boulanger, Denise S. M., et al.
Publicado: (2022)

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design
por: Jappe, Emma C., et al.
Publicado: (2020)

Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_abo0s6ob863joqd7f8ckdm8tao